Last week, more than 30 experts representing payers, pharmacists, integrated delivery systems, health economists and analysts, patient advocates, academicians, pharmaceutical manufacturers, and other key decision-makers in the managed care setting convened virtually for AMCP’s Partnership Forum “Biosimilars: Policy, Practice, and Post-Marketing Surveillance to Support Treatment and Coverage Decisions” to identify key actions that support the use and development of biosimilars in the U.S. health care system.
AMCP Foundation recognizes Montrell Taylor, 2021 PharmD Candidate at Howard University College of Pharmacy, for his successful completion of the Genentech Evidence for Access Summer Internship Program.
AMCP Foundation proudly recognizes two student pharmacists who recently completed the Managed Care: Oncology Summer Internship program with the generous support of Pfizer, Inc.’s US Oncology Organized Customer Team.
AMCP Foundation recognizes two student pharmacists from the University of Southern California and University of Washington for the successful completion of the Specialized Summer Internship Program in Health Outcomes, sponsored by AbbVie, Inc.
Today, the Administration released a final rule, Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals, along with an interim final rule, Most Favored Nations (MFN) Model. In response, AMCP CEO Susan A. Cantrell, RPh, CAE, released the following statement.
Today, representative organizations of America’s pharmaceutical supply and payment chain, including prescription and over-the-counter brand and generic manufacturers; pharmacies and pharmacists across all practice settings, including health systems and hospitals, community, specialty, and managed care; supermarkets; wholesalers; pharmaceutical quality standard developers; employers and other health plan sponsors; health insurance providers; and pharmacy benefit managers, released guiding principles for the safe efficacious development, distribution, and allocation of vaccine(s) to achieve mass immunization against the coronavirus (COVID-19).
This week, AMCP Nexus 2020 Virtual will welcome more than 1,800 managed care pharmacy professionals from across the country for five days of focused, essential learning opportunities centered on “making the way for innovation” in managed care pharmacy.
During AMCP Legislative Day 2020, 40 AMCP members met with lawmakers in targeted congressional offices on AMCP’s key issues to explain the value of managed care pharmacy in the broader health care system.
More than 30 experts representing health plans, integrated delivery systems, health economists, providers, academicians, pharmaceutical manufacturers, and other professionals gathered for AMCP’s Partnership Forum to address the challenges in managing and providing timely access to rare and orphan disease therapies.
The leaders of 12 U.S. pharmacy organizations today issued the following statement celebrating the U.S. Department of Human Services order this week that expands the role of pharmacists in providing vaccines to children.
This afternoon, the Trump administration released Executive Orders focused on pharmaceutical pricing. Solving this crisis and delivering real change will require elected officials and health care stakeholders to develop practical, informed, and market-based solutions that make health care and prescription drugs more affordable and accessible to all Americans.
AMCP Foundation is pleased to announce that a team of student pharmacists from University of California, San Francisco School of Pharmacy took top honors in the 20th Annual National Student Pharmacy & Therapeutics (P&T) Competition.